Last 0.38 MYR
Change Today 0.00 / 0.00%
Volume 1.1M
HOV On Other Exchanges
Kuala Lumpur
As of 3:59 AM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

hovid bhd (HOV) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/30/14 - 0.48
52 Week Low
12/16/14 - 0.32
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HOVID BHD (HOV)

Related News

No related news articles were found.

hovid bhd (HOV) Related Businessweek News

No Related Businessweek News Found

hovid bhd (HOV) Details

Hovid Berhad manufactures and sells pharmaceutical and herbal products. The company offers ethical drugs; dietary supplements; and consumer products, such as disinfectants and cosmetics, as well as herbal tea and Tocovid SupraBio, a health supplement product. In addition, the company engages in establishing, maintaining, and operating laboratories and shops for carrying on chemical, physical, and other research and development activities in medicine, chemistry, industry, and other fields. Further, it is involved in trading of medical supplies, pharmaceutical products, and consumer products. The company operates in Asia, Africa, North and South America, Europe, and the Pacific Island. Hovid Berhad is based in Ipoh, Malaysia.

hovid bhd (HOV) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hovid bhd (HOV) Key Developments

Hovid Berhad Announces Unaudited Consolidated for the First Quarter Ended September 30, 2014

Hovid Berhad announced unaudited consolidated for the first quarter ended September 30, 2014. For the quarter, the company reported revenue of MYR 48.910 million against MYR 40.432 million a year ago. Profit from operations was MYR 9.426 million against MYR 7.837 million a year ago. Profit before tax was MYR 7.657 million against MYR 6.070 million a year ago. Profit attributable to owners of the company was MYR 5.809 million or 0.60 sen per diluted share against MYR 4.579 million or 0.53 sen per diluted share a year ago. Net cash from operating activities was MYR 6.785 million against MYR 4.661 million a year ago. Acquisition of property, plant and equipment was MYR 1.496 million against MYR 1.473 million a year ago.

Hovid Berhad, Annual General Meeting, Nov 25, 2014

Hovid Berhad, Annual General Meeting, Nov 25, 2014., at 10:30 China Standard Time. Location: Ballroom, Impiana Hotel Ipoh. Agenda: To receive the Audited Financial Statements for the financial year ended 30 June 2014 together with the Reports of the Directors and Independent Auditors thereon; to approve the payment of Directors' fees of MYR 373,183 for the financial year ended 30 June 2014; to re-elect directors; to re-appoint auditors; and to consider special business.

Hovid Announces Redesignation of YM Raja Shamsul Kamal Bin Raja Shahruzzaman as Independent & Non Executive Director

Hovid announced that YM Raja Shamsul Kamal Bin Raja Shahruzzaman is redesignated from Independent Non-Executive Director to Senior Independent Non-Executive Director with effect from 30 May 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HOV:MK 0.38 MYR 0.00

HOV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HOV.
View Industry Companies

Industry Analysis


Industry Average

Valuation HOV Industry Range
Price/Earnings 17.3x
Price/Sales 1.4x
Price/Book 1.6x
Price/Cash Flow 10.4x
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HOVID BHD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at